Home › Immunoblastic Lymphadenopathy › Connecticut › New Haven
Immunoblastic Lymphadenopathy clinical trials in New Haven, CT
3 studies for Immunoblastic Lymphadenopathy are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
RecruitingPhase 3
- Yale University, New Haven
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
RecruitingPhase 1
- Clinical Trial Site, New Haven
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Yale University (Data Collection Only), New Haven
Immunoblastic Lymphadenopathy trials in other cities
- New York City, NY5 studies
- Houston, TX4 studies
- Miami, FL4 studies
- Chicago, IL4 studies
- Durham, NC4 studies
- Edison, NJ3 studies
- St. Louis, MO3 studies
- Atlanta, GA3 studies
- Boston, MA3 studies
- Baldwin Park, CA3 studies
- Rochester, MN3 studies
- Columbus, OH3 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer37 studies
- Cancer (all types)34 studies
- Lung Cancer23 studies
- Metastatic Cancer23 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Prostate Cancer21 studies
- Colorectal Cancer21 studies
- Ovarian Cancer21 studies
- Acute Myeloid Leukemia19 studies
- Alcohol Use Disorder (AUD)17 studies
- Opioid Overdose17 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.